单核苷酸多态性 (SNP)基因型鉴定:技术与全球市场
市场调查报告书
商品编码
1517505

单核苷酸多态性 (SNP)基因型鉴定:技术与全球市场

Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets

出版日期: | 出版商: BCC Research | 英文 110 Pages | 订单完成后即时交付

价格

全球单核苷酸多态性 (SNP)基因型鉴定市场规模预计将从 2024 年的320 亿美元增加到 2029 年底的 855 亿美元,预测期内复合年增长率为 21.7%。

北美地区预计将从 2024 年的 138 亿美元成长到 2029年终的370 亿美元,复合年增长率为 21.9%。此外,欧洲地区预计将从 2024 年的 830 万美元成长到 2029年终的217 亿美元,复合年增长率为 21.2%。

该报告调查了全球单核苷酸多态性(SNP)基因型鉴定市场,并提供了市场概况、市场影响因素和市场机会分析、新兴技术和技术发展趋势、市场规模趋势和预测以及各种细分。

目录

第一章执行摘要

  • 市场展望
  • 调查范围
  • 市场概况

第二章 市场概况

  • 概述
  • 用于突变分析的 SNP
  • SNP的定义
  • SNP研究方法
  • SNP分类
  • PESTEL分析

第三章市场动态

  • 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会

第四章新兴科技与发展

  • 单核苷酸多态性晶片
  • 法医学中的SNP基因分型技术
  • 人工智慧在 SNP 基因基因型鉴定的应用

第五章市场区隔分析

  • 市场趋势
  • 细分细分
  • 全球 SNP基因型鉴定市场:依技术分类
  • 微阵列和基因晶片
  • SNP定序
  • TaqMan Allelic Discrimination
  • Applied Biosystems SNPlex Platform
  • MassArray Maldi-TOF
  • 其他的
  • 全球 SNP基因型鉴定市场:依应用分类
  • 药物和药物基因组学
  • 诊断研究
  • 农业生物技术
  • 动物遗传学
  • 植物改良
  • 水产养殖
  • 其他的
  • 地域分布
  • 全球 SNP基因型鉴定市场:按地区
  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

第六章 竞争讯息

  • 资金筹措
  • 主要企业
  • 主要企业采取的关键策略
  • 合伙
  • 其他策略

第 7 章 SNP基因型鉴定市场的永续性:ESG 视角

  • 市场ESG表现
  • SNP基因型鉴定产业的 ESG 实践
  • 环保性能
  • 社会表现
  • 管治绩效
  • ESG风险评估
  • BCC的结语

第8章附录

  • 调查方法
  • 缩写词
  • 参考
  • 公司简介
  • AGILENT TECHNOLOGIES INC.
  • BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
  • BIO-RAD LABORATORIES INC.
  • CYTIVA
  • ENZO BIOCHEM INC.
  • EPIGENDX
  • F. HOFFMANN-LA ROCHE LTD.
  • ILLUMINA INC.
  • QIAGEN
  • STANDARD BIOTOOLS
  • THERMO FISHER SCIENTIFIC INC.
Product Code: BIO139B

The global market for single nucleotide polymorphism (SNP) is expected to grow from $32.0 billion in 2024 and is projected to reach $85.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.7% during the forecast period of 2024 to 2029.

The North American SNP market is expected to grow from $13.8 billion in 2024 and is projected to reach $37.0 billion by the end of 2029, at a CAGR of 21.9% during the forecast period of 2024 to 2029.

The European SNP market is expected to grow from $8.3 million in 2024 and is projected to reach $21.7 billion by the end of 2029, at a CAGR of 21.2% during the forecast period of 2024 to 2029.

Report Scope:

This report covers the worldwide market for SNP genotyping, with the market segmented by technology and application. It provides an in-depth analysis of the SNP genotyping market, including estimates and trends through 2029. In this report, the market is divided into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029. This report also uses analytical frameworks such as PESTEL, examines the competitive landscape, and explores trends in ESG and funding.

Report Includes:

  • 37 data tables and 44 additional tables
  • An overview of the global market for single nucleotide polymorphism (SNP) genotyping
  • Analyses of global market trends, with data from 2021-2023, estimates for 2024, and projected CAGRs through 2029
  • Evaluation of the current market size and revenue growth prospects specific to SNP genotyping, along with a market share analysis by technology, application, and region
  • Discussion of the advantages of the most frequently used SNP genotyping techniques, such as Sequenom's MassArray DNA analysis platform, Bruker's MALDI-TOF array, SNP pyrosequencing, microarrays and gene chips, and Applied Biosystems' (now part of Thermo Fisher Scientific) SNPlex and TaqMan
  • Analysis of the regulatory framework and policies affecting the industry
  • Discussion of the ESG practices of, as well as challenges for, companies
  • Analysis of the key companies' market shares and their proprietary technologies, strategic alliances and patents
  • Company profiles of the leading players, including Agilent Technologies Inc., F. Hoffman-La Roche Ltd., Illumina Inc., Qiagen, and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Overview
  • SNP for Mutational Analysis
  • SNP Definition
  • Methods of Studying SNPs
  • Classification of SNPs
  • PESTEL Analysis
  • Political
  • Economic
  • Social
  • Technological
  • Environmental
  • Legal

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Declining Prices of DNA Sequencing Methods
  • Demand for Personalized Treatments
  • Personalized Medicine and SNP Genotyping in the Drug Development Process
  • Increasing Demand for Genome Analysis in Plants and Animal Livestock
  • Market Restraints
  • Reimbursement Policies
  • Market Opportunities
  • Increasing Applications of SNP Genotyping
  • Rising Investments in Genomics Research

Chapter 4 Emerging Technologies and Developments

  • SNP-Chip
  • SNP Genotyping Technologies in Forensic Science
  • Artificial Intelligence in SNP Genotyping

Chapter 5 Market Segmentation Analysis

  • Market Trends
  • Segmentation Breakdown
  • Global Market for SNP Genotyping, by Technology
  • Microarrays and GeneChips
  • SNP Pyrosequencing
  • TaqMan Allelic Discrimination
  • Applied Biosystems SNPlex Platform
  • MassArray Maldi-TOF
  • Other SNP Genotyping Technologies
  • Global Market for SNP Genotyping, by Application
  • Pharmaceuticals and Pharmacogenomics
  • Diagnostic Research
  • Agricultural Biotechnology
  • Animal Genetics
  • Plant Improvements
  • Aquaculture
  • Other Applications
  • Geographic Breakdown
  • Global Market for SNP Genotyping, by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 6 Competitive Intelligence

  • Funding
  • Leading Companies
  • Key Strategies Adopted by Players
  • Partnerships
  • Other Strategies

Chapter 7 Sustainability in the SNP Genotyping Market: An ESG Perspective

  • ESG Performance in the Market
  • ESG Practices in the SNP Genotyping Industry
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • ESG Risk Ratings
  • Concluding Remarks from BCC Research

Chapter 8 Appendix

  • Methodology
  • Acronyms
  • References
  • Company Profiles
  • AGILENT TECHNOLOGIES INC.
  • BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
  • BIO-RAD LABORATORIES INC.
  • CYTIVA
  • ENZO BIOCHEM INC.
  • EPIGENDX
  • F. HOFFMANN-LA ROCHE LTD.
  • ILLUMINA INC.
  • QIAGEN
  • STANDARD BIOTOOLS
  • THERMO FISHER SCIENTIFIC INC.

List of Tables

  • Summary Table : Global Market for SNP Genotyping, by Region, Through 2029
  • Table 1 : SNP Public Databases
  • Table 2 : Role of SNP Genotyping in Stages of the Drug Development Process
  • Table 3 : Global Market for SNP Genotyping, by Technology, Through 2029
  • Table 4 : Global Market for Microarrays and GeneChips in SNP Genotyping, by Region, Through 2029
  • Table 5 : Global Market for Pyrosequencing in SNP Genotyping, by Region, Through 2029
  • Table 6 : Global Market for TaqMan Allelic Discrimination in SNP Genotyping, by Region, Through 2029
  • Table 7 : Global Market for Applied Biosystems SNPlex Platform in SNP Genotyping, by Region, Through 2029
  • Table 8 : Global Market for MassArray Maldi-TOF in SNP Genotyping, by Region, Through 2029
  • Table 9 : Global Market for Other Technologies in SNP Genotyping, by Region, Through 2029
  • Table 10 : Global Market for SNP Genotyping, by Application, Through 2029
  • Table 11 : Global Market for Pharmaceuticals and Pharmacogenomics Applications in SNP Genotyping, by Region, Through 2029
  • Table 12 : Global Market for Diagnostic Research Applications in SNP Genotyping, by Region, Through 2029
  • Table 13 : Global Market for Agricultural Biotechnology Applications in SNP Genotyping, by Region, Through 2029
  • Table 14 : Global Market for Animal Genetics Applications in SNP Genotyping, by Region, Through 2029
  • Table 15 : Global Market for Plant Improvement Applications in SNP Genotyping, by Region, Through 2029
  • Table 16 : Global Market for Aquaculture Applications in SNP Genotyping, by Region, Through 2029
  • Table 17 : Global Market for Other Applications in SNP Genotyping, by Region, Through 2029
  • Table 18 : Global Market for SNP Genotyping, by Region, Through 2029
  • Table 19 : North American Market for SNP Genotyping, by Technology, Through 2029
  • Table 20 : North American Market for SNP Genotyping, by Application, Through 2029
  • Table 21 : National Genome Projects in Europe
  • Table 22 : European Market for SNP Genotyping, by Technology, Through 2029
  • Table 23 : European Market for SNP Genotyping, by Application, Through 2029
  • Table 24 : Asia-Pacific Market for SNP Genotyping, by Technology, Through 2029
  • Table 25 : Asia-Pacific Market for SNP Genotyping, by Application, Through 2029
  • Table 26 : RoW Market for SNP Genotyping, by Technology, Through 2029
  • Table 27 : RoW Market for SNP Genotyping, by Application, Through 2029
  • Table 28 : Major Private and Public Funding Organizations
  • Table 29 : National Human Genome Research Institute, NIH Funded and Completed Projects
  • Table 30 : Leaders in the SNP Genotyping Market, 2023
  • Table 31 : Business Expansions in the Global SNP Genotyping Market, 2021-2024
  • Table 32 : Product Launches in the Global SNP Genotyping Market, 2021-2024
  • Table 33 : Collaborations and Agreements in the Global SNP Genotyping Market, 2022 and 2023
  • Table 34 : Partnerships in the Global SNP Genotyping Market, 2021-2024
  • Table 35 : Other Business Strategies Adopted by Key Players in SNP Genotyping Market, 2021-2024
  • Table 36 : Key Focus Areas in ESG Metrics
  • Table 37 : Environmental Performance Initiatives in the SNP Genotyping Market
  • Table 38 : Social Performance Initiatives in the SNP Genotyping Market
  • Table 39 : Governance Performance Initiatives in the SNP Genotyping Market
  • Table 40 : ESG Rankings for SNP Genotyping Companies, 2023*
  • Table 41 : Abbreviations Used in This Report
  • Table 42 : Agilent Technologies Inc.: Company Snapshot
  • Table 43 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
  • Table 44 : Agilent Technologies Inc.: Product Portfolio
  • Table 45 : Agilent Technologies Inc.: News/Key Developments, 2021-2023
  • Table 46 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Company Snapshot
  • Table 47 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Product Portfolio
  • Table 48 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): News/Key Developments, 2021-2023
  • Table 49 : Bio-Rad Laboratories Inc.: Company Snapshot
  • Table 50 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
  • Table 51 : Bio-Rad Laboratories Inc.: Product Portfolio
  • Table 52 : Cytiva: Company Snapshot
  • Table 53 : Cytiva: Product Portfolio
  • Table 54 : Cytiva: News/Key Developments, 2023
  • Table 55 : Enzo Biochem Inc.: Company Snapshot
  • Table 56 : Enzo Biochem Inc.: Financial Performance, FY 2022 and 2023
  • Table 57 : Enzo Biochem Inc.: Product Portfolio
  • Table 58 : Enzo Biochem Inc.: News/Key Developments, 2022
  • Table 59 : EpigenDx.: Company Snapshot
  • Table 60 : EpigenDx: Service Portfolio
  • Table 61 : F. Hoffmann-La Roche Ltd.: Company Snapshot
  • Table 62 : F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
  • Table 63 : F. Hoffman-La Roche Ltd.: Product Portfolio
  • Table 64 : F. Hoffman-La Roche Ltd.: News/Key Developments, 2021
  • Table 65 : Illumina Inc.: Company Snapshot
  • Table 66 : Illumina Inc.: Financial Performance, FY 2022 and 2023
  • Table 67 : Illumina Inc.: Services Portfolio
  • Table 68 : Illumina Inc.: News/Key Developments, 2022 and 2023
  • Table 69 : Qiagen: Company Snapshot
  • Table 70 : Qiagen: Financial Performance, FY 2022 and 2023
  • Table 71 : Qiagen: Product Portfolio
  • Table 72 : Qiagen: News/Key Developments, 2023 and 2024
  • Table 73 : Standard BioTools: Company Snapshot
  • Table 74 : Standard BioTools: Financial Performance, FY 2022 and 2023
  • Table 75 : Standard BioTools: Product Portfolio
  • Table 76 : Standard BioTools: News/Key Developments, 2022 and 2023
  • Table 77 : Thermo Fisher Scientific Inc.: Company Snapshot
  • Table 78 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
  • Table 79 : Thermo Fisher Scientific Inc.: Product Portfolio
  • Table 80 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2024

List of Figures

  • Summary Figure : Global Market for SNP Genotyping, by Region, 2021-2029
  • Figure 1 : Classification of SNPs
  • Figure 2 : PESTEL Analysis: SNP Genotyping Market
  • Figure 3 : Market Dynamics of SNP Genotyping
  • Figure 4 : Average Cost Per Genome: Y-o-Y Trend, 2011-2022
  • Figure 5 : Snapshot of SNP Genotyping Market: Business Strategies
  • Figure 6 : Global Market Share for SNP Genotyping, by Technology, 2024
  • Figure 7 : Global Market for Microarrays and GeneChips in SNP Genotyping, by Region, 2021-2029
  • Figure 8 : Global Market for Pyrosequencing in SNP Genotyping, by Region, 2021-2029
  • Figure 9 : Global Market for TaqMan Allelic Discrimination in SNP Genotyping, by Region, 2021-2029
  • Figure 10 : Global Market for Applied Biosystems SNPlex in SNP Genotyping, by Region, 2021-2029
  • Figure 11 : Global Market for MassArray Maldi-TOF in SNP Genotyping, by Region, 2021-2029
  • Figure 12 : Global Market for Other Technologies in SNP Genotyping, by Region, 2021-2029
  • Figure 13 : Global Market Share for SNP Genotyping, by Application, 2024
  • Figure 14 : Global Market for Pharmaceuticals and Pharmacogenomics Applications in SNP Genotyping, by Region, 2021-2029
  • Figure 15 : Global Market for Diagnostic Research Applications in SNP Genotyping, by Region, 2021-2029
  • Figure 16 : Major Applications of SNP Genotyping in Agricultural Biotechnology
  • Figure 17 : Global Market for Agricultural Biotechnology Applications in SNP Genotyping, by Region, 2021-2029
  • Figure 18 : Applications of SNP Genotyping in Animal Genetics
  • Figure 19 : Global Market for Animal Genetics Applications in SNP Genotyping, by Region, 2021-2029
  • Figure 20 : Global Market for Plant Improvement Applications in SNP Genotyping, by Region, 2021-2029
  • Figure 21 : Global Market for Aquaculture Applications in SNP Genotyping, by Region, 2021-2029
  • Figure 22 : Global Market for Other Applications in SNP Genotyping, by Region, 2021-2029
  • Figure 23 : Global Market Share for SNP Genotyping, by Region, 2024
  • Figure 24 : Share of New Genetic Tests in the U.S., by CLIA-certified Laboratory, 2012 to 2022
  • Figure 25 : North American Market for SNP Genotyping, by Technology, 2021-2029
  • Figure 26 : North American Market for SNP Genotyping, by Application, 2021-2029
  • Figure 27 : European Market for SNP Genotyping, by Technology, 2021-2029
  • Figure 28 : European Market for SNP Genotyping, by Application, 2021-2029
  • Figure 29 : Drivers of the Asia-Pacific Market for SNP Genotyping
  • Figure 30 : Asia-Pacific Market for SNP Genotyping, by Technology, 2021-2029
  • Figure 31 : Asia-Pacific Market for SNP Genotyping, by Application, 2021-2029
  • Figure 32 : RoW Market for SNP Genotyping, by Technology, 2021-2029
  • Figure 33 : RoW Market for SNP Genotyping, by Application, 2021-2029
  • Figure 34 : Share of the Global SNP Genotyping Market, Competitive Intelligence, by Strategy, 2021-2024
  • Figure 35 : How a Strong ESG Proposition Benefits Businesses
  • Figure 36 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 37 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 38 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 39 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 40 : Enzo Biochem Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 41 : F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
  • Figure 42 : F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
  • Figure 43 : Illumina Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 44 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 45 : Qiagen: Revenue Share, by Business Unit, FY 2023
  • Figure 46 : Qiagen: Revenue Share, by Country/Region, FY 2023
  • Figure 47 : Standard BioTools: Revenue Share, by Business Unit, FY 2023
  • Figure 48 : Standard BioTools: Revenue Share, by Country/Region, FY 2023
  • Figure 49 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 50 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023